Skip to content
Home/Companies/Pharma/Xellia Pharmaceuticals

Xellia Pharmaceuticals

Pharma·Denmark·Active·13yr hold
Entry
2013
Hold
13yr
Status
Active

Who owns Xellia Pharmaceuticals?

Xellia Pharmaceuticals is a Danish Pharma company, currently owned by Novo Holdings since 2013.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Investor
Novo Holdings
Novo Holdings Principal Investments · 1999 · Buyout

Key facts

HQDenmark
SectorPharma
StatusActive

More from Novo Holdings Principal Investments

Other portfolio companies in the same fund.

Tempus AI
Active
HealthTechUS· 2026
Benchmark Genetics
Active
AgTechUK· 2025
KalVista Pharmaceuticals
Active
PharmaUS· 2025
Schott Poonawalla
Active
IndustrialsIndia· 2025
Catalent
Active
PharmaUS· 2024
Inozyme Pharma
Exited 2025
BiotechUS· 2023
to BioMarin Pharmaceutical

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Xellia Pharmaceuticals?

Xellia Pharmaceuticals is currently owned by Novo Holdings, through Novo Holdings Principal Investments, since 2013.

When did Novo Holdings acquire Xellia Pharmaceuticals?

Novo Holdings acquired Xellia Pharmaceuticals in 2013.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue